Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
ID: 331834Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/331834

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-132.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity for confirmatory efficacy clinical trials of non-pharmacological interventions for mental disorders (R01 Clinical Trial Required). This initiative aims to support research that rigorously tests the effectiveness of innovative therapeutic and preventive interventions for mental health conditions in both adults and children, addressing significant therapeutic needs and emphasizing an experimental therapeutics approach. The NIMH plans to allocate approximately $27 million for this initiative, with no budget limits on grant applications, although they must align with project requirements, and the maximum project period is five years. Interested applicants can find more information and submit inquiries via the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV, with applications due by October 15, 2024.

    Point(s) of Contact
    FBOWebmaster@OD.NIH.GOV
    Files
    Title
    Posted
    PAR-21-132-Full-Announcement.html
    PAR-21-132.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the National Institute of Mental Health (NIMH), has issued a Funding Opportunity Announcement (FOA) focused on confirmatory efficacy clinical trials of non-pharmacological interventions for mental disorders (PAR-21-132). The purpose is to support research aimed at testing the effectiveness of novel therapeutic and preventive interventions for mental health conditions in adults and children, addressing critical therapeutic needs. Applicants are invited to submit applications for clinical trials designed to rigorously assess these interventions and their impact on specific psychological mechanisms and clinical outcomes. The FOA highlights the need for a robust scientific rationale, evidence of prior preliminary efficacy, and clear plans for measuring target engagement, emphasizing an experimental therapeutics approach. Grant budgets are not limited but must align with project needs, and the maximum project period is five years. The NIMH aims to allocate $27 million for this initiative. Eligible applicants include various educational institutions, non-profits, state and local governments, and foreign entities, emphasizing collaboration and appropriate methodology.
    Similar Opportunities
    Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R01 grant to support clinical trials aimed at evaluating the effectiveness of treatment, preventive, and service interventions in mental health. The primary objectives of this funding opportunity include conducting rigorous assessments of pharmacologic, psychosocial, and combined interventions, as well as service-level strategies that enhance access and quality of mental health care within community settings. This initiative is crucial for addressing significant public health challenges and advancing evidence-based practices in mental health service delivery. The total funding available is $27 million, with a maximum project period of five years, and applications are due by October 15, 2024. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-21-130.html.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for the Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). This initiative aims to support pilot research focused on innovative psychosocial intervention strategies for both adults and children, emphasizing the experimental therapeutic approach to address underlying mechanisms of mental disorders. The funding will facilitate exploratory clinical trials for up to three years, with no specific budget limits, provided they reflect actual project needs, and applications must demonstrate a strong scientific rationale and empirical support. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of October 15, 2024.
    Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required). This initiative aims to support innovative clinical trials that investigate novel interventions for mental health conditions, including schizophrenia, depression, and anxiety, with a focus on establishing proof of mechanism and target engagement in the R61 phase and confirming findings on a larger scale in the R33 phase. The total funding commitment for this initiative is $27 million for FY 2022, and eligible applicants include a diverse range of entities such as higher education institutions, nonprofits, and various government organizations, both domestic and foreign. Interested parties should note that the application deadline is October 15, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries.
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for research projects aimed at evaluating the effectiveness of post-acute interventions and services for mental health conditions affecting youth, adults, and older adults. This initiative encourages clinical trials designed to assess therapeutic strategies that consolidate treatment gains, manage residual symptoms, prevent relapse, and enhance treatment adherence, with a focus on producing statistically powered studies that address chronic or relapsing mental health issues. The program emphasizes the importance of improving long-term mental health outcomes, particularly for underserved populations, and applications are open to a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the deadline for submissions is January 25, 2025, and can find further details and guidelines at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders" (R61/R33 Clinical Trial Required). This initiative aims to support pilot research that develops and tests innovative psychosocial interventions targeting mental disorders in both adults and children, focusing on early-stage exploratory clinical trials to assess how these interventions engage biological, cognitive, or behavioral targets linked to mental health issues. Successful projects will receive funding for up to two years in the R61 phase for preliminary studies, with the potential for an additional three years in the R33 phase contingent upon meeting specified milestones. Interested applicants must adhere to strict guidelines regarding human subject protections and submit their applications through Grants.gov by the deadline of October 15, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering the Exploratory/Developmental Research Grant (R21), which aims to support high-risk and innovative research projects that align with the mission of advancing mental health research. This grant is specifically designed for the early stages of research that may lead to significant breakthroughs in clinical and biomedical fields related to mental health, with a funding limit of $275,000 over a two-year period. Eligible applicants include a diverse range of organizations such as higher education institutions, non-profits, and tribal governments, emphasizing the importance of innovative approaches in addressing critical barriers in mental health research. Interested parties should note that applications are due by January 7, 2025, and must adhere to NIH guidelines, with further inquiries directed to grantsinfo@nih.gov.
    Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33 - Clinical Trial Required). This funding opportunity aims to support early-stage clinical trials that evaluate novel pharmacologic or device-based interventions targeting mental disorders such as depression, schizophrenia, and anxiety, with a focus on interventions that demonstrate unique mechanisms of action and potential clinical benefits. The NIH intends to commit $27 million in funding, and proposals must include clinical trial designs with budgets reflecting actual project needs over a maximum period of three years, emphasizing innovative interventions that address unmet therapeutic needs. Interested applicants can find more information and guidelines at the NIH website, with a submission deadline of October 15, 2024.
    Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity titled "Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)." This grant aims to support innovative research that enhances the delivery and quality of mental health services, particularly for underserved populations, by addressing issues such as access, usability, quality, and scalability of these services. Eligible applicants include a wide range of organizations, including educational institutions, non-profits, and governmental bodies, with a focus on projects that incorporate community input and comply with NIH guidelines. Interested parties should note that the application deadline is January 7, 2025, and further details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-095.html. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Clinical Studies of Mental Illness (Collaborative R01)" aimed at supporting multidisciplinary clinical studies focused on mental health, particularly in areas such as genetics, biomarkers, and various mental illnesses. This initiative encourages collaboration across multiple sites to enhance sample sizes and diversity in participant recruitment, specifically targeting health disparity populations. The program allows for a project period of up to five years with no explicit budget limits, although proposed budgets must be well justified. Interested applicants, including various educational and nonprofit institutions, should submit their applications by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. For more details, applicants can refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-050.html.
    First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for first-in-human and early-stage clinical trials of novel investigational drugs or devices aimed at treating psychiatric disorders, under the U01 Clinical Trial Required mechanism. This initiative seeks to support innovative clinical trials that address significant unmet medical needs in psychiatric care, emphasizing the formation of partnerships between biomedical researchers and industry to expedite the development of effective therapies. The total funding available for this program is $27 million, with project durations ranging from 1 year for first-in-human studies to up to 4 years for comprehensive Phase II studies. Interested applicants, including higher education institutions, nonprofits, and governmental entities, must adhere to strict application guidelines, with a submission deadline of October 15, 2024. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement page at http://grants.nih.gov/grants/guide/pa-files/PAR-21-133.html.